Mild to moderate uncomplicated & complicated Urinary tract Infections
0.5 – 1g iv/M
12 hrly
7-10
4
Sever complicated Urinary tract Infections
2 g iv
12 hrly
10
5
Mild to moderate Skin and skin structural Infections
2 g iv
12 hrly
10
6
Intra-abdominal Infections
2 g iv
12 hrly
7-10
Offer Date: 08-APR-13
Egytig 50mg (Tigecycline 50mg Vial)
Indications :
Complicated Skin & Skin Structure infections.
Complicated Intra-Abdominal infections.
Community – Acquired Bacterial Pneumonia.
Dosage : Initial dose of 100mg, followed by 50mg every 12 hrs. IV should be administered approx. 30-60 mins. every 12 hrs. Renal Insufficiency : No dosage adjustment required. Hepatic Insufficiency : No dosages adjustment required in mild & moderate hepatic impairment (Child Pugh A and Child Pugh B). In patient with severe hepatic impairment (Child Pugh C) should be 100 mg followed by a reduced maintenance dose of 25 mg every 12 hours.
Offer Date: 08-APR-13
Clinzucia 600mg (Clindamycin 600mg Amp.)
Indications :
Serious infection caused by susceptible strains of streptococci, pneumocci & staphylococci.
Lower respiratory infections including bronchitis, pneumonia, emphyema and lung abscess.
Bone and joint infections including staphylococcal osteomyelitis and septic arthritis.
Pelvic infections including endometritis, cellulitis, vaginal cuff infection, tubo-ovarian abscesses, salpingitis and pelvic inflammatory disease .
Skin and soft tissue infections including acne, furuncles, cellulitis, impetigo, abscesses, and wound infections.
Dosage : The recommended dosages are : Clinzucia Injection :
Adults :
Serious infections : 600-1200mg/day in 2, 3 or 4 equal doses either IM or IV administration. More Severe Infection : 1200 -2700 mg/day in 2, 3 or 4 equal doses (IM or IV)
Neonates : 15 to 20mg/kg/day in 3 to 4 equal doses.
Pediatric Patients : 20 to 40mg/kg/day in 3 or 4 equal doses either IM or IV administration.
Intravenous Dosage : 2 Vial 0.6 g or 1 Vial of 1.2 g 6-8 hourly. Pediatric : 30 mg /kg in divided dose. Renally Impaired Patients :
CrCl (ml/min)
Recommended Dosage
>30
No changes
10-30
1.2g injection initially then 600mg 12 hourly.
<10
1.2g injection initially then 600mg 12 Daily.
Offer Date: 08-APR-13
Cefoprim (Cefuroxime Sodium for Injection USP 1.5 G)
Indications :
Upper Respiratory Tract Infections
Urinary Tract Infections
Skin & Soft Tissue Infections
Bone & Joint Infections due to S.aureus
Dosage :
Adult :
Parenteral : 750 mg to 1.5 g every 8 hours for 5 to 10 days. Oral : 250 mg to 500 mg BID for 10 days. Paediatric :30 - 100mg/kg/day BID / QID. Renally Impaired Patients :
CrCl (ml/min)
Recommended Dosage
>10
No changes
<10
Gives 250mg 24 hr
Offer Date: 08-APR-13
Cefoprim 750mg
(Cefuroxime Sodium For Injection USP 750 mg) Indications :
Lower Respiratory Tract Infections
Septicemia
Perioperative Prophylaxis
Gonorrhea
Meningitis
Urinary Tract Infections
Skin & Soft Tissue Infections
Bone & Joint Infections due to S.aureus
Dosage :
Adult :
Parenteral : 750 mg to 1.5 g every 8 hours for 5 to 10 days. Maximum Dose : 3gm every 8 hrs. Paediatric :50 - 100mg/kg/day TID / QID. Renally Impaired Patients :
CrCl (ml/min)
Recommended Dosage
>20
No changes
10 -20
750mg BID
Offer Date: 08-APR-13
Cefoprim (Cefuroxime Axetil Tablets USP 500 Mg)
Indications :
Upper Respiratory Tract Infections
Urinary Tract Infections
Skin & Soft Tissue Infections
Bone & Joint Infections due to S.aureus
Dosage :
Adult :
Parenteral : 750 mg to 1.5 g every 8 hours for 5 to 10 days. Oral : 250 mg to 500 mg BID for 10 days. Paediatric :30 - 100mg/kg/day BID / QID. Renally Impaired Patients :
Acute Bacterial Exacerdation of Chronic Bronchitis & Secondary Bacterial Infection of Acute Bronchitis
Uncomplicated Urinary Tract Infections
Uncomplicated Skin & Soft Tissue Infections
Bone & Joint Infections due to S.aureus
Uncomplicated gonorrhea
Early Lyme Disease
Dosage
Oral : 250 mg to 500 mg BID for 10 days. Uncomplicated Gonorrhea : 1gm OD Paediatric :30 - 100mg/kg/day BID / QID. Renally Impaired Patients :
CrCl (ml/min)
Recommended Dosage
>10
No changes
<10
250mg
Offer Date: 08-APR-13
Amphotericin B Lipid Complex Injection 50 Mg
Empirical therapy for presumed fungal infections
Treatment for confirmed fungal infections
Treatment of patients with Aspergillus spp., Candida spp. and/or Cryptococcus spp. infections refractory to amphotericin B deoxycholate
In patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate
Treatment of Visceral leishmaniasis
Dosage
The recommended initial dose of Amphotin-Lip for each indication for adult and pediatric patients is as follows :
Indications
Dose (Mg/Kg/day)
Empirical therapy
2.5 - 3
Systematic Fungal infections
Aspergillus
5
Candida
5
Cryptococcus
5
Cryptococcal Maningitis in HIV infected Patients
5
Offer Date: 08-APR-13
Amphotin - Lip 10mg
Amphotericin B Lipid Complex Injection 10 mg
Indications :
Empirical therapy for presumed fungal infections.
Treatment for systemic fungal infections.
Cryptococcal meningitis in HIV.
In patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate.
Treatment of Visceral leishmaniasis.
Dosage : The recommended initial dose of Amphotin-Lip for each indication for adult and pediatric patients is as follows :
Indication
Dose (mg/Kg/day)
Empirical therapy
3mg/kg/day
Systematic Fungal infections
Aspergillus
5
Candida
5
Cryptococcus
5
Cryptococcal Maningitis in HIV infected Patients
6mg/kg/day for approx. 120min.
Offer Date: 08-APR-13
Contact Us
United Biotech Private Limited
Mr. Suresh Kumar / Mr. Sandeep / Mr. Gulab
(International Marketing)
FC- B-1 Extension, Mohan Co- Operative Industrial Estate, Mathura Road,,
New Delhi -
110 044,
Delhi,
India